Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-24-011444
Filing Date
2024-01-22
Accepted
2024-01-19 21:50:29
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-1/A d613667ds1a.htm S-1/A 1598649
2 EX-5.1 d613667dex51.htm EX-5.1 19172
3 EX-5.2 d613667dex52.htm EX-5.2 8340
4 EX-23.1 d613667dex231.htm EX-23.1 3606
5 EX-FILING FEES d613667dexfilingfees.htm EX-FILING FEES 34039
6 GRAPHIC g613667dsp26.jpg GRAPHIC 2738
7 GRAPHIC g613667dsp27.jpg GRAPHIC 1651
8 GRAPHIC g613667dsp62.jpg GRAPHIC 10098
9 GRAPHIC g613667g0104013617344.jpg GRAPHIC 18503
10 GRAPHIC g613667g0104021039339.jpg GRAPHIC 4286
11 GRAPHIC g613667g1202020638135.jpg GRAPHIC 3681
  Complete submission text file 0001193125-24-011444.txt   1722508
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-275870 | Film No.: 24546947
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)